Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Woburn, MA, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Azurity Pharmaceuticals, Inc. announced today the availability of Javadin™ (clonidine hydrochloride) oral solution, the only FDA-approved,...
-
Woburn, MA, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Azurity Pharmaceuticals and Sebela Pharmaceuticals announced today Azurity’s successful acquisition of Sebela’s Bowel Prep Franchise, including two...
-
New York, NY and Woburn, MA, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Azurity Pharmaceuticals names Ogilvy Health as public relations and marketing agency of record. Ogilvy Health's mandate will focus on...
-
Woburn, MA, Oct. 24, 2025 (GLOBE NEWSWIRE) -- Azurity Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved Javadin™ (clonidine hydrochloride) oral...
-
Woburn, MA, Oct. 17, 2025 (GLOBE NEWSWIRE) -- Azurity Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved FerabrightTM (ferumoxytol injection), the...